Testosterone levels as a marker of prognosis to Goserelin treatment in metastatic breast cancer-Reference-Cited by-同舟云学术

Testosterone levels as a marker of prognosis to Goserelin treatment in metastatic breast cancer

Published:1994-01 Issue:11 Volume:30 Page:1629-1631
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Secreto G.,Boracchi P.,Buzzoni R.,Venturelli E.,Cavalleri A.,Dolci S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference11 articles.

1. Castration and oestrogen therapy;Stoll,1972

2. Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival;Dixon;Br J Cancer,1990

3. Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer;Kaufman;J Clin Oncol,1989

4. Ovariectomy alone or in combination with dexamethasone in patients with advanced breast cancer and high levels of testosterone excretion;Grattarola;J Natl Cancer Inst,1976

5. Ovariectomy alone or in combination with dexamethasone in patients with advanced breast cancer and high levels of testosterone or androstanediol excretion;Secreto;Rev Endocrine-Related Cancer Suppl,1984

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of free and deconjugated testosterone and epitestosterone in urine using SPME and LC–MS/MS;Bioanalysis;2011-01

2. Safety and Adverse Effects of Androgens: How to Counsel Patients;Mayo Clinic Proceedings;2004-04

3. Methods for urinary testosterone analysis;Journal of Chromatography B: Biomedical Sciences and Applications;1995-09

4. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues;The Journal of Steroid Biochemistry and Molecular Biology;1995-06